Aurobindo Pharma Board approves ₹800 cr share buyback plan

Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date Aurobindo Pharma’s Board has approved the generic…